News Releases
- Algernon Provides Update on Phase 2 Human Testing of Ifenprodil for COVID-19 April 2, 2020
- Algernon Submits for Ethics Approval for Phase 2 IPF and Chronic Cough Study March 30, 2020
- Algernon Provides an Overview of its NP-120 (Ifenprodil) Program for COVID-19 March 24, 2020
- Algernon Appoints U.S. Company for cGMP Manufacturing of NP-120 (Ifenprodil) for COVID-19 Clinical Trials March 23, 2020
- Algernon Appoints Novotech as CRO For Phase 2 Coronavirus Ifenprodil Trial March 20, 2020
- Algernon to Support Planned Phase 2 Trial of Ifenprodil for Coronavirus March 19, 2020
- Algernon Contacts Gates Foundation Regarding Funding for New Coronavirus Treatments March 13, 2020
- Algernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency Use March 13, 2020
- Algernon Announces Exercise of Warrants and Broker Warrants March 11, 2020
- Algernon Announces Coronavirus Update Featured on BioPub Hosted by Dr. KSS MD PhD March 10, 2020